MarketPulse
S

$SCYX

3 articles found
1 positive
1 negative
1 neutral
BenzingaBenzinga··Rishabh Mishra

Stock Futures Rise Despite Iran Tensions as Defense Stocks Surge on Contracts

U.S. stock futures gained Tuesday on falling oil prices and diplomatic progress, despite defensive strikes on Iran. Defense and space stocks led gains.
ZSLUNRESLTBOXSCYXstock marketS&P 500
GlobeNewswire Inc.GlobeNewswire Inc.··Na

SCYNEXIS Grants Inducement Awards to New VP Under Nasdaq Rule 5635

SCYNEXIS grants 125,000 stock options at $0.93/share and 20,000 RSUs to new VP under Nasdaq inducement rules.
SCYXrestricted stock unitsstock options
BenzingaBenzinga··Globe Newswire

SCYNEXIS Expands Pipeline With $8M PXL-770 Acquisition, Eyes Rare Kidney Disease Market

SCYNEXIS completes acquisition of PXL-770 AMPK activator for ADPKD treatment. Deal includes $8M upfront, up to $188M milestones; Phase 2 study planned for late 2026.
GSKSCYXacquisitionclinical development
$SCYX Stock News & Sentiment | MarketPulse